NCT02016677

Brief Summary

The purpose of the study is to collect data regarding the aesthetic outcomes of patients who had breast reduction surgery and /or mastopexy in terms such as scaring, patient satisfaction, breast ptosis assessment including taking photographs and filling questionnaires.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2013

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

December 10, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 20, 2013

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

December 23, 2015

Status Verified

October 1, 2015

Enrollment Period

1.9 years

First QC Date

December 10, 2013

Last Update Submit

December 22, 2015

Conditions

Keywords

Breast reductionMastopexySagging

Outcome Measures

Primary Outcomes (1)

  • Measuring the aesthetic outcomes of pre /post- surgical breast ptosis

    Breast measurements consists on: * Breast cup size * Distortions or skin retractions * Symmetry between the two breasts * Ptosis grade evaluated on the basis of an I-IV scale * Methods to measure breast shape and symmetry * Skin texture (soft or hard) * Skin consistency * Nipple location on the breast mound scored on a scale of 1 - 5 * Areola diameter (mm) * The shape of the breast scored on a scale of 1 - 5 * Scar Appearance evaluation -VAS score * Patient satisfaction questionnaires

    during 5 years post- surgically

Study Arms (1)

observation

no specific treatment. Long term observation the results of any breast lifting or reduction surgeries

Eligibility Criteria

Age30 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Female Patients, 30 years of age or older referred for elective breast reduction surgery and /or mastopxy

You may qualify if:

  • Female patient older than 30 years of age.
  • Patients willing to participate as evidenced by signing the written informed consent.
  • Patient that was found by her physician illegible for breast reduction surgery and /or mastopxy

You may not qualify if:

  • \. Active psychiatric illness, cognitive or sensory impairment. 2. Physical impairment that may prevent filling out a paper and pencil survey or responding to interview questions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Plastic Surgery Department The Tel Aviv Sourasky Medical Center

Tel Aviv, Israel

Location

MeSH Terms

Conditions

Gigantomastia

Study Officials

  • Arik Zaretski, MD

    TASMC

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2013

First Posted

December 20, 2013

Study Start

December 1, 2013

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

December 23, 2015

Record last verified: 2015-10

Locations